ECSP066627A - Indazol-o-glucosidos sustituidos - Google Patents

Indazol-o-glucosidos sustituidos

Info

Publication number
ECSP066627A
ECSP066627A ECSP066627A ECSP066627A EC SP066627 A ECSP066627 A EC SP066627A EC SP066627 A ECSP066627 A EC SP066627A EC SP066627 A ECSP066627 A EC SP066627A
Authority
EC
Ecuador
Prior art keywords
indazol
glucosids
replaced
diabetes
syndrome
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
Maud Urbanski
Mona Patel
Philip Rybczynski
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP066627A publication Critical patent/ECSP066627A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ECSP066627 2003-11-12 2006-06-08 Indazol-o-glucosidos sustituidos ECSP066627A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51938103P 2003-11-12 2003-11-12
US57972204P 2004-06-15 2004-06-15

Publications (1)

Publication Number Publication Date
ECSP066627A true ECSP066627A (es) 2006-10-25

Family

ID=36715443

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP066627 ECSP066627A (es) 2003-11-12 2006-06-08 Indazol-o-glucosidos sustituidos

Country Status (2)

Country Link
EC (1) ECSP066627A (is)
IS (1) IS8443A (is)

Also Published As

Publication number Publication date
IS8443A (is) 2006-05-09

Similar Documents

Publication Publication Date Title
CR8402A (es) Indazol-o-glucosidos sustitutos
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
UA86042C2 (en) Substituted indazole-o-glucosides
UY28572A1 (es) Compuestos novedosos
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
NO20081160L (no) Benzimidazoltiofen forbindelser
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
SE0301700D0 (sv) Novel compounds
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
UY27894A1 (es) Derivados de cinamida.
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
DOP2006000268A (es) Agentes antibacterianos
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI0607351A2 (pt) métodos para tratamento de linfomas empregando uma combinação de agente quimioterapêutico e il-2 e opcionalmente um anticorpo anti-cd20
UY28731A1 (es) Compuestos quimicos
CL2009000599A1 (es) Compuestos derivados de 4,5-dihidro-1h-pirazol(4,3-g)benzotiazol sustituidos; composicion farmaceutica; utiles para el tratamiento y prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes, entre otras.
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
ECSP066627A (es) Indazol-o-glucosidos sustituidos
UY27394A1 (es) Pedidos con actividad anti- angiogéna.
UY28382A1 (es) Derivados de 2-aminobenzoilo
ECSP066628A (es) Indol-o-glucosidos sustituidos
GT200600173A (es) Forma purificada de tranaproget